These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 16734498)

  • 1. Long-term pharmacotherapy for post-traumatic stress disorder.
    Davis LL; Frazier EC; Williford RB; Newell JM
    CNS Drugs; 2006; 20(6):465-76. PubMed ID: 16734498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations.
    Asnis GM; Kohn SR; Henderson M; Brown NL
    Drugs; 2004; 64(4):383-404. PubMed ID: 14969574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment-resistant anxiety disorders: A literature review of drug therapy strategies].
    Ammar G; Naja WJ; Pelissolo A
    Encephale; 2015 Jun; 41(3):260-5. PubMed ID: 25439852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapy for anxiety and comorbid alcohol use disorders.
    Ipser JC; Wilson D; Akindipe TO; Sager C; Stein DJ
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007505. PubMed ID: 25601826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder.
    Rothbaum BO; Killeen TK; Davidson JR; Brady KT; Connor KM; Heekin MH
    J Clin Psychiatry; 2008 Apr; 69(4):520-5. PubMed ID: 18278987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy for post-traumatic stress disorder: a comprehensive review.
    Davis LL; English BA; Ambrose SM; Petty F
    Expert Opin Pharmacother; 2001 Oct; 2(10):1583-95. PubMed ID: 11825301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term treatment with paroxetine increases verbal declarative memory and hippocampal volume in posttraumatic stress disorder.
    Vermetten E; Vythilingam M; Southwick SM; Charney DS; Bremner JD
    Biol Psychiatry; 2003 Oct; 54(7):693-702. PubMed ID: 14512209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychopharmacologic treatment of traumatized youth.
    Stamatakos M; Campo JV
    Curr Opin Pediatr; 2010 Oct; 22(5):599-604. PubMed ID: 20802335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Three paradigms in the treatment of posttraumatic stress disorder].
    Martényi F
    Neuropsychopharmacol Hung; 2005 Mar; 7(1):11-21. PubMed ID: 16167463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic treatment of acute and chronic stress following trauma: 2006.
    Davidson JR
    J Clin Psychiatry; 2006; 67 Suppl 2():34-9. PubMed ID: 16602813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ziprasidone Augmentation of SSRI Antidepressants in Posttraumatic Stress Disorder: A Randomized, Placebo-Controlled Pilot Study of Augmentation Therapy.
    Hamner MB; Hernandez-Tejada MA; Zuschlag ZD; Agbor-Tabi D; Huber M; Wang Z
    J Clin Psychopharmacol; 2019; 39(2):153-157. PubMed ID: 30640209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial.
    Brady K; Pearlstein T; Asnis GM; Baker D; Rothbaum B; Sikes CR; Farfel GM
    JAMA; 2000 Apr; 283(14):1837-44. PubMed ID: 10770145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological therapy for post-traumatic stress disorder: a systematic review and meta-analysis of monotherapy, augmentation and head-to-head approaches.
    Hoskins MD; Bridges J; Sinnerton R; Nakamura A; Underwood JFG; Slater A; Lee MRD; Clarke L; Lewis C; Roberts NP; Bisson JI
    Eur J Psychotraumatol; 2021; 12(1):1802920. PubMed ID: 34992738
    [No Abstract]   [Full Text] [Related]  

  • 15. Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study.
    Stein MB; Kline NA; Matloff JL
    Am J Psychiatry; 2002 Oct; 159(10):1777-9. PubMed ID: 12359687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment.
    Rapaport MH; Endicott J; Clary CM
    J Clin Psychiatry; 2002 Jan; 63(1):59-65. PubMed ID: 11838628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in inflammatory biomarkers before and after SSRI therapy in PTSD: A review.
    Sagarwala R; Nasrallah HA
    Ann Clin Psychiatry; 2019 Nov; 31(4):292-297. PubMed ID: 31675389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open-label trial of escitalopram in the treatment of posttraumatic stress disorder.
    Robert S; Hamner MB; Ulmer HG; Lorberbaum JP; Durkalski VL
    J Clin Psychiatry; 2006 Oct; 67(10):1522-6. PubMed ID: 17107242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD).
    Hetrick SE; Purcell R; Garner B; Parslow R
    Cochrane Database Syst Rev; 2010 Jul; (7):CD007316. PubMed ID: 20614457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychopharmacologic treatment of posttraumatic stress disorder in children and adolescents: a review.
    Strawn JR; Keeshin BR; DelBello MP; Geracioti TD; Putnam FW
    J Clin Psychiatry; 2010 Jul; 71(7):932-41. PubMed ID: 20441729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.